Literature DB >> 11053835

Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II.

G Kryger1, M Harel, K Giles, L Toker, B Velan, A Lazar, C Kronman, D Barak, N Ariel, A Shafferman, I Silman, J L Sussman.   

Abstract

Structures of recombinant wild-type human acetylcholinesterase and of its E202Q mutant as complexes with fasciculin-II, a 'three-finger' polypeptide toxin purified from the venom of the eastern green mamba (Dendroaspis angusticeps), are reported. The structure of the complex of the wild-type enzyme was solved to 2.8 A resolution by molecular replacement starting from the structure of the complex of Torpedo californica acetylcholinesterase with fasciculin-II and verified by starting from a similar complex with mouse acetylcholinesterase. The overall structure is surprisingly similar to that of the T. californica enzyme with fasciculin-II and, as expected, to that of the mouse acetylcholinesterase complex. The structure of the E202Q mutant complex was refined starting from the corresponding wild-type human acetylcholinesterase structure, using the 2.7 A resolution data set collected. Comparison of the two structures shows that removal of the charged group from the protein core and its substitution by a neutral isosteric moiety does not disrupt the functional architecture of the active centre. One of the elements of this architecture is thought to be a hydrogen-bond network including residues Glu202, Glu450, Tyr133 and two bridging molecules of water, which is conserved in other vertebrate acetylcholinesterases as well as in the human enzyme. The present findings are consistent with the notion that the main role of this network is the proper positioning of the Glu202 carboxylate relative to the catalytic triad, thus defining its functional role in the interaction of acetylcholinesterase with substrates and inhibitors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053835     DOI: 10.1107/s0907444900010659

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  59 in total

1.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site.

Authors:  Yves Bourne; Palmer Taylor; Zoran Radić; Pascale Marchot
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

2.  Weak conservation of structural features in the interfaces of homologous transient protein-protein complexes.

Authors:  Govindarajan Sudha; Prashant Singh; Lakshmipuram S Swapna; Narayanaswamy Srinivasan
Journal:  Protein Sci       Date:  2015-09-08       Impact factor: 6.725

3.  Structural insights into substrate traffic and inhibition in acetylcholinesterase.

Authors:  Jacques-Philippe Colletier; Didier Fournier; Harry M Greenblatt; Jure Stojan; Joel L Sussman; Giuseppe Zaccai; Israel Silman; Martin Weik
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

4.  Naturally occurring variations in the human cholinesterase genes: heritability and association with cardiovascular and metabolic traits.

Authors:  Anne M Valle; Zoran Radic; Brinda K Rana; Vafa Mahboubi; Jennifer Wessel; Pei-an Betty Shih; Fangwen Rao; Daniel T O'Connor; Palmer Taylor
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

5.  Characterization of a complete cycle of acetylcholinesterase catalysis by ab initio QM/MM modeling.

Authors:  Alexander V Nemukhin; Sofia V Lushchekina; Anastasia V Bochenkova; Anna A Golubeva; Sergei D Varfolomeev
Journal:  J Mol Model       Date:  2008-03-15       Impact factor: 1.810

6.  Inactivation of an invertebrate acetylcholinesterase by sulfhydryl reagents: the roles of two cysteines in the catalytic gorge of the enzyme.

Authors:  Leo Pezzementi; Melissa Rowland; Matthew Wolfe; Igor Tsigelny
Journal:  Invert Neurosci       Date:  2006-04-04

7.  Bisquaternary pyridinium oximes: Comparison of in vitro reactivation potency of compounds bearing aliphatic linkers and heteroaromatic linkers for paraoxon-inhibited electric eel and recombinant human acetylcholinesterase.

Authors:  Sandip B Bharate; Lilu Guo; Tony E Reeves; Douglas M Cerasoli; Charles M Thompson
Journal:  Bioorg Med Chem       Date:  2009-11-27       Impact factor: 3.641

8.  Predicting inhibitors of acetylcholinesterase by regression and classification machine learning approaches with combinations of molecular descriptors.

Authors:  Dmitriy Chekmarev; Vladyslav Kholodovych; Sandhya Kortagere; William J Welsh; Sean Ekins
Journal:  Pharm Res       Date:  2009-07-15       Impact factor: 4.200

9.  Selective and irreversible inhibitors of aphid acetylcholinesterases: steps toward human-safe insecticides.

Authors:  Yuan-Ping Pang; Sanjay K Singh; Yang Gao; T Leon Lassiter; Rajesh K Mishra; Kun Yan Zhu; Stephen Brimijoin
Journal:  PLoS One       Date:  2009-02-04       Impact factor: 3.240

10.  Design, expression and characterization of mutants of fasciculin optimized for interaction with its target, acetylcholinesterase.

Authors:  Oz Sharabi; Yoav Peleg; Efrat Mashiach; Eyal Vardy; Yacov Ashani; Israel Silman; Joel L Sussman; Julia M Shifman
Journal:  Protein Eng Des Sel       Date:  2009-07-30       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.